Todd Hobbs, MD, is vice president and chief medical officer for Novo Nordisk in North America, where he leads the organization’s focus on the implications of diabetes for the patient, healthcare system and healthcare professionals.
We can never lose faith in the “Eureka” moments that bring innovation to life. Yes, as a science-driven company, we’re placing bets on medicines most likely to demonstrate meaningful efficacy benefits and acceptable safety profiles in rigorous clinical trials.
Our Chief Medical Officer has diabetes and a child with diabetes.
We talk with Todd Hobbs, vice president and chief medical officer for Novo Nordisk in North America.